Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Rowe

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
FASEB Bioadvances|July 18, 2020
Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinomaSam Faulkner, Nathan Griffin, Christopher W Rowe, et al.
World Journal of Surgery|August 30, 2025
Development of a Decision Aid for Patients With Low-Risk Thyroid Cancer: A Mixed-Methods Analysis of Feedback From Both Patient and CliniciansChristine J O'Neill, Ahmad Alam, Michelle Chapman, et al.
ANZ Journal of Surgery|July 1, 2023
Thyroid cancer patient reported outcome measures in clinical practice: analysing acceptability and optimizing recruitmentChristine J O'Neill, Harriet Morris-Baguley, Ahmad S Alam, et al.
International Journal of Molecular Sciences|November 29, 2019
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological VariablesChristopher W Rowe, Tony Dill, Sam Faulkner, et al.
Thyroid : Official Journal of the American Thyroid Association|July 10, 2025
Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following SurgeryChristine J O'Neill, Christopher W Rowe, Harriet Morris-Baguley, et al.
BMC Endocrine Disorders|November 29, 2019
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosisChristopher W Rowe, Sam Faulkner, Jonathan W Paul, et al.
Scientific Reports|May 27, 2018
The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lungFangfang Gao, Nathan Griffin, Sam Faulkner, et al.
The American Journal of Pathology|October 18, 2017
Neurotrophin Receptors TrkA, p75<sup>NTR</sup>, and Sortilin Are Increased and Targetable in Thyroid CancerSam Faulkner, Philip Jobling, Christopher W Rowe, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
FASEB Bioadvances|July 18, 2020
Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinomaSam Faulkner, Nathan Griffin, Christopher W Rowe, et al.
World Journal of Surgery|August 30, 2025
Development of a Decision Aid for Patients With Low-Risk Thyroid Cancer: A Mixed-Methods Analysis of Feedback From Both Patient and CliniciansChristine J O'Neill, Ahmad Alam, Michelle Chapman, et al.
ANZ Journal of Surgery|July 1, 2023
Thyroid cancer patient reported outcome measures in clinical practice: analysing acceptability and optimizing recruitmentChristine J O'Neill, Harriet Morris-Baguley, Ahmad S Alam, et al.
International Journal of Molecular Sciences|November 29, 2019
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological VariablesChristopher W Rowe, Tony Dill, Sam Faulkner, et al.
Thyroid : Official Journal of the American Thyroid Association|July 10, 2025
Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following SurgeryChristine J O'Neill, Christopher W Rowe, Harriet Morris-Baguley, et al.
BMC Endocrine Disorders|November 29, 2019
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosisChristopher W Rowe, Sam Faulkner, Jonathan W Paul, et al.
Scientific Reports|May 27, 2018
The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lungFangfang Gao, Nathan Griffin, Sam Faulkner, et al.
The American Journal of Pathology|October 18, 2017
Neurotrophin Receptors TrkA, p75<sup>NTR</sup>, and Sortilin Are Increased and Targetable in Thyroid CancerSam Faulkner, Philip Jobling, Christopher W Rowe, et al.
Pageof 3